Convergence Financial, LLC Johnson & Johnson Transaction History
Convergence Financial, LLC
- $509 Billion
- Q1 2025
A detailed history of Convergence Financial, LLC transactions in Johnson & Johnson stock. As of the latest transaction made, Convergence Financial, LLC holds 6,200 shares of JNJ stock, worth $938,246. This represents 0.2% of its overall portfolio holdings.
Number of Shares
6,200
Previous 5,101
21.54%
Holding current value
$938,246
Previous $738 Million
39.36%
% of portfolio
0.2%
Previous 0.15%
Shares
4 transactions
Others Institutions Holding JNJ
# of Institutions
4,651Shares Held
1.73BCall Options Held
25MPut Options Held
15.1M-
Vanguard Group Inc Valley Forge, PA234MShares$35.4 Billion0.72% of portfolio
-
Black Rock Inc. New York, NY198MShares$30 Billion0.67% of portfolio
-
State Street Corp Boston, MA134MShares$20.2 Billion0.94% of portfolio
-
Geode Capital Management, LLC Boston, MA59.4MShares$8.99 Billion0.79% of portfolio
-
Jpmorgan Chase & CO New York, NY54.1MShares$8.18 Billion0.7% of portfolio
About JOHNSON & JOHNSON
- Ticker JNJ
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,614,479,872
- Market Cap $396B
- Description
- Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...